IL33/ST2 contributes to airway remodeling via p-JNK MAPK/STAT3 signaling pathway in OVA-induced allergic airway inflammation in mice

References

• Ashtma GIf. 2016 GINA Report, Global strategy for Asthma Management and Prevention; 2016.
   Google Scholar
• Holgate ST, Wenzel S, Postma DS, Weiss ST, Renz H, Sly PD. Asthma. Nat Rev Dis Primers. 2015;1:15025. doi: 10.1038/nrdp.2015.25.
   PubMed Web of Science ®Google Scholar
• Pelaia G, Vatrella A, Busceti MT, et al. Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma. Mediators Inflamm. 2015;2015:879783. doi: 10.1155/2015/879783.
   PubMed Web of Science ®Google Scholar
• Undem BJ, McAlexander M, Hunter DD. Neurobiology of the upper and lower airways. Allergy 1999;54(Suppl 57):81–93.
   PubMed Web of Science ®Google Scholar
• Beckett PA, Howarth PH. Pharmacotherapy and airway remodelling in asthma? Thorax 2003;58(2):163–174.
   PubMed Web of Science ®Google Scholar
• Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol. 2011;128(3):451–462. quiz 463-4. doi: 10.1016/j.jaci.2011.04.047.
   PubMed Web of Science ®Google Scholar
• Baraket M, Oliver BGG, Burgess JK, Lim S, King GG, Black JL. Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study. Respir Res. 2012;13(1):11.
   PubMed Web of Science ®Google Scholar
• Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23(5):479–490. doi: 10.1016/j.immuni.2005.09.015.
   PubMed Web of Science ®Google Scholar
• Drake LY, Kita H. IL-33: biological properties, functions, and roles in airway disease. Immunol Rev. 2017;278(1):173–184. doi: 10.1111/imr.12552.
   PubMed Web of Science ®Google Scholar
• Mahmutovic Persson I, Menzel M, Ramu S, Cerps S, Akbarshahi H, Uller L. IL-1beta mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation. Respir Res 2018;19(1):16.
   PubMed Web of Science ®Google Scholar
• Wang W, Li Y, Lv Z. Bronchial allergen challenge of patients with atopic asthma triggers an alarmin (IL-33, TSLP, and IL-25) response in the airways epithelium and submucosa. J Immunol 2018;201(8):2221–2231.
   PubMed Web of Science ®Google Scholar
• Christianson CA, Goplen NP, Zafar I, et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol. 2015;136(1):59–68.e14. doi: 10.1016/j.jaci.2014.11.037.
   PubMed Web of Science ®Google Scholar
• Hamzaoui A, Berraies A, Kaabachi W, Haifa M, Ammar J, Kamel H. Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children. J Asthma. 2013;50(8):803–809. doi: 10.3109/02770903.2013.816317.
   PubMed Web of Science ®Google Scholar
• Lloyd CM. IL-33 family members and asthma - bridging innate and adaptive immune responses. Curr Opin Immunol. 2010;22(6):800–806. doi: 10.1016/j.coi.2010.10.006.
   PubMed Web of Science ®Google Scholar
• Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun. 2009;386(1):181–185. doi: 10.1016/j.bbrc.2009.06.008.
   PubMed Web of Science ®Google Scholar
• Lee HY, Rhee CK, Kang JY, et al. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Exp Lung Res. 2014;40(2) :66–76. doi: 10.3109/01902148.2013.870261.
   PubMed Web of Science ®Google Scholar
• Ramaprakash H, Shibata T, Duffy KE, et al. Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model. Am J Pathol. 2011;179(1):104–115. doi: 10.1016/j.ajpath.2011.03.032.
   PubMed Web of Science ®Google Scholar
• Saglani S, Lui S, Ullmann N, et al. IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol. 2013;132(3):676–685.e13. doi: 10.1016/j.jaci.2013.04.012.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bian C, Wu J, et al. [IL-33 promotes airway remodeling in a mouse model of asthma via ERK1/2 signaling pathway]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2016;32(5):590–594.
   PubMedGoogle Scholar
• Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22(2) :153–183. doi: 10.1210/edrv.22.2.0428.
   PubMed Web of Science ®Google Scholar
• Zeng S, Wu J, Liu J, Qi F, Liu B. IL-33 Receptor (ST2) signalling is important for regulation of Th2-mediated airway inflammation in a murine model of acute respiratory syncytial virus infection. Scand J Immunol. 2015;81(6):494–501. doi: 10.1111/sji.12284.
   PubMed Web of Science ®Google Scholar
• Wang J, Li F, Yang M, et al. FIZZ1 promotes airway remodeling through the PI3K/Akt signaling pathway in asthma. Exp Ther Med. 2014;7(5):1265–1270. doi: 10.3892/etm.2014.1580.
   PubMed Web of Science ®Google Scholar
• Guo Z, Wu J, Zhao J, et al. [IL-33/ST2 promotes airway remodeling in asthma by activating the expression of fibronectin 1 and type 1 collagen in human lung fibroblasts]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014;30(9):975–979.
   PubMedGoogle Scholar
• Prefontaine D, Nadigel J, Chouiali F, et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol. 2010;125(3):752–754. doi: 10.1016/j.jaci.2009.12.935.
   PubMed Web of Science ®Google Scholar
• Kurowska-Stolarska M, Stolarski B, Kewin P, et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol. 2009;183(10):6469–6477. doi: 10.4049/jimmunol.0901575.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang W, Lv Z, et al. Elevated Expression of IL-33 and TSLP in the airways of human asthmatics in vivo: A potential biomarker of severe refractory disease. JI. 2018;200(7):2253–2262. doi: 10.4049/jimmunol.1701455.
   Web of Science ®Google Scholar
• Watanabe M, Nakamoto K, Inui T, et al. Serum sST2 levels predict severe exacerbation of asthma. Respir Res. 2018;19(1):169. doi: 10.1186/s12931-018-0872-2.
   PubMed Web of Science ®Google Scholar
• Li D, Guabiraba R, Besnard AG, et al. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J Allergy Clin Immunol. 2014;134(6):1422–1432.e11. doi: 10.1016/j.jaci.2014.05.011.
   PubMed Web of Science ®Google Scholar
• Saluja R, Hawro T, Eberle J, Church MK, Maurer M. Interleukin-33 promotes the proliferation of mouse mast cells through ST2/MyD88 and p38 MAPK-dependent and Kit-independent pathways. J Biol Regul Homeost Agents 2014;28(4):575–585.
   PubMed Web of Science ®Google Scholar
• Ryu W-I, Lee H, Kim JH, Bae HC, Ryu HJ, Son SW. IL-33 induces Egr-1-dependent TSLP expression via the MAPK pathways in human keratinocytes. Exp Dermatol. 2015;24(11):857–863. doi: 10.1111/exd.12788.
   PubMed Web of Science ®Google Scholar
• Liu S, Mi W-L, Li Q, et al. Spinal IL-33/ST2 Signaling Contributes to Neuropathic Pain via Neuronal CaMKII-CREB and Astroglial JAK2-STAT3 Cascades in Mice. Anesthesiology 2015;123(5):1154–1169. doi: 10.1097/ALN.0000000000000850.
   PubMed Web of Science ®Google Scholar
• Kumar A, Singh UK, Kini SG, et al. JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases. Future Med Chem. 2015;7(15):2065–2086. doi: 10.4155/fmc.15.132.
   PubMed Web of Science ®Google Scholar
• Wu H-M, Fang L, Shen Q-Y, Liu R-Y. SP600125 promotes resolution of allergic airway inflammation via TLR9 in an OVA-induced murine acute asthma model. Mol Immunol. 2015; 67(2):311–316. doi: 10.1016/j.molimm.2015.06.016.
   PubMed Web of Science ®Google Scholar
• Redhu N, Shan L, Al-Subait D, et al. IgE induces proliferation in human airway smooth muscle cells: role of MAPK and STAT3 pathways. Allergy Asthma Clin Immunol. 2013;9(1):41. doi: 10.1186/1710-1492-9-41.
   PubMed Web of Science ®Google Scholar
• Desai P, Yang J, Tian B, et al. Mixed-effects model of epithelial-mesenchymal transition reveals rewiring of signaling networks. Cell Signal. 2015;27(7):1413–1425. doi: 10.1016/j.cellsig.2015.03.024.
   PubMed Web of Science ®Google Scholar
• Wu J, Liu F, Zhao J, et al. Thymic stromal lymphopoietin promotes asthmatic airway remodelling in human lung fibroblast cells through STAT3 signalling pathway. Cell Biochem Funct. 2013;31(6):496–503. doi: 10.1002/cbf.2926.
   PubMed Web of Science ®Google Scholar